3.46
-0.08(-2.26%)
Currency In USD
| Previous Close | 3.54 |
| Open | 3.55 |
| Day High | 3.85 |
| Day Low | 3.44 |
| 52-Week High | 16.31 |
| 52-Week Low | 1.6 |
| Volume | 2.01M |
| Average Volume | 975,274 |
| Market Cap | 256.92M |
| PE | -2.53 |
| EPS | -1.37 |
| Moving Average 50 Days | 3.76 |
| Moving Average 200 Days | 3.22 |
| Change | -0.08 |
If you invested $1000 in Perspective Therapeutics, Inc. (CATX) 10 years ago, it would be worth $235.37 as of September 08, 2025 at a share price of $3.46. Whereas If you bought $1000 worth of Perspective Therapeutics, Inc. (CATX) shares 5 years ago, it would be worth $541.47 as of September 08, 2025 at a share price of $3.46.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Perspective Therapeutics Appoints Biotech Veteran Joel Sendek as Chief Financial Officer
GlobeNewswire Inc.
Sep 04, 2025 11:00 AM GMT
Distinguished career as a Wall Street analyst and significant CFO experience, bringing keen insights and understanding of finance and the life sciences investment landscapeSEATTLE, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc.
Perspective Therapeutics Appoints Maya Martinez-Davis to Board of Directors
GlobeNewswire Inc.
Sep 03, 2025 11:00 AM GMT
SEATTLE, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body, today announced that i
Perspective Therapeutics to Participate in Upcoming September Conferences
GlobeNewswire Inc.
Aug 26, 2025 11:00 AM GMT
SEATTLE, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body, today announced that me